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Transcriptional regulatory networks underlying the
reprogramming of spermatogonial stem cells to
multipotent stem cells
Hoe-Su Jeong1,5, Jinhyuk Bhin2,5, Hyung Joon Kim1, Daehee Hwang2,3, Dong Ryul Lee4 and Kye-Seong Kim1
Spermatogonial stem cells (SSCs) are germline stem cells located along the basement membrane of seminiferous tubules in
testes. Recently, SSCs were shown to be reprogrammed into multipotent SSCs (mSSCs). However, both the key factors and
biological networks underlying this reprogramming remain elusive. Here, we present transcriptional regulatory networks (TRNs)
that control cellular processes related to the SSC-to-mSSC reprogramming. Previously, we established intermediate SSCs (iSSCs)
undergoing the transition to mSSCs and generated gene expression proﬁles of SSCs, iSSCs and mSSCs. By comparing these
proﬁles, we identiﬁed 2643 genes that were up-regulated during the reprogramming process and 15 key transcription factors
(TFs) that regulate these genes. Using the TF-target relationships, we developed TRNs describing how these TFs regulate three
pluripotency-related processes (cell proliferation, stem cell maintenance and epigenetic regulation) during the reprogramming.
The TRNs showed that 4 of the 15 TFs (Oct4/Pou5f1, Cux1, Zfp143 and E2f4) regulated cell proliferation during the early
stages of reprogramming, whereas 11 TFs (Oct4/Pou5f1, Foxm1, Cux1, Zfp143, Trp53, E2f4, Esrrb, Nfyb, Nanog, Sox2 and
Klf4) regulated the three pluripotency-related processes during the late stages of reprogramming. Our TRNs provide a model for
the temporally coordinated transcriptional regulation of pluripotency-related processes during the SSC-to-mSSC reprogramming,
which can be further tested in detailed functional studies.
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INTRODUCTION
Spermatogonial stem cells (SSCs) are the germline stem
cells located along the basement membrane of seminiferous
tubules in mammalian testes. SSCs are self-renewing and
undifferentiated cells in the testicular microenvironment.
In response to differentiation cues, they can be differentiated
into one specialized cell lineage, spermatozoa. Recent studies
have shown that these unipotent SSCs can be reprogrammed
into multipotent SSCs (mSSCs) under deﬁned culture
conditions.1–6 Unlike embryonic stem cells (ESCs) and induced
pluripotent stem cells (iPSCs) that have several issues, such as
tumorigenic potential and ethical concerns, hindering their
application in regenerative medicine, these mSSCs can serve as
a pluripotent stem cell source free from these issues.
Previous studies have focused on both the generation
and characterization of mSSCs. Comparative analyses of gene
expression proﬁles revealed that mSSCs were similar to ESCs,
compared with iPSCs, SSCs and neural stem cells (NSCs).6,7
In addition, mSSCs were also similar to ESCs in their miRNA
expression proﬁles. For example, mSSCs highly express a set of
ESC-speciﬁc miRNAs, including the miR-290 and miR-302
families.8 Moreover, a comparative analysis of proteome
proﬁles demonstrated that mSSCs had a highly similar
proteome to that of ESCs. Furthermore, DNA methylation
proﬁles, as well as an analysis of the methylation of
pluripotency marker gene loci, showed signiﬁcant similarities
between mSSCs and ESCs.9 These similarities between mSSCs
and ESCs at multiple molecular levels strongly support the idea
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that mSSCs acquire naïve pluripotent states similar to those of
ESCs.10
Transcriptional regulatory networks (TRNs) are essential
to understanding the reprogramming of SSCs to mSSCs.
Pluripotency-inducing transcription factors (TFs), such as
Oct4/Pou5f1, Sox2, Myc and/or Klf4, have key roles in the
reprogramming and generation of iPSCs.11,12 Several studies
have also reported a few other factors that inﬂuence the
reprogramming of SSCs to mSSCs. For example, SSCs derived
from p53-knock-out mice can be converted into ES-like
cells more quickly than those derived from wild-type mice,
implying that p53 negatively inﬂuences the reprogramming
process.5 The microRNAs that regulate the levels of
mRNAs involved in SSC reprogramming, such as miR-372,
miR-373 and miR-470, can act as potential regulators of the
reprogramming.13 Despite all these ﬁndings, the TRNs
underlying SSC reprogramming remain unclear.
Here, we present a systems approach used to identify novel
TFs that are important for reprogramming and to decode a
TRN underlying the reprogramming, which describes how the
novel and known TFs control cellular processes related to the
reprogramming of SSCs to mSSCs. We ﬁrst generated inter-
mediate SSCs (iSSCs) undergoing the transition to mSSCs and
then performed gene expression proﬁling of SSCs, iSSCs and
mSSCs. Comparisons of the gene expression proﬁles revealed
the reprogramming-related genes that increased in expression
during the course of the reprogramming of SSCs to mSSCs.
By identifying key TFs that regulate the reprogramming-related
genes, we developed a TRN that describes the regulation
of three reprogramming-related processes (cell proliferation,
aerobic glycolysis and epigenetic regulation) by these TFs,
which could improve the understanding of the reprogramming
of SSCs to mSSCs.
MATERIALS AND METHODS
Microarray data analysis
Total RNA was isolated from SSCs, iSSCs and mSSCs using an RNeasy
mini kit (Qiagen, Valencia, CA, USA), and RNA integrity was assessed
using a Bioanalyzer 2100 instrument (Agilent, Santa Clara, CA, USA).
The RNA integrity numbers (RINs) were higher than 8 for all samples.
Biological replicates were obtained from independently cultured SSCs
(n= 3), mSSCs (n= 3) and iSSCs (n= 2). For all replicates, the total
RNA was reversed-transcribed into cDNA, ampliﬁed and then
hybridized onto an Illumina MouseRef-8-v2-BeadChip gene expres-
sion array, according to the standard protocols of the manufacturer.
The array was then scanned using the BeadStation 500 System
(Illumina, San Diego, CA, USA) to quantify the signal of the probes.
We normalized the log2 intensities of all probes using the quantile
normalization method.14 The raw data were deposited into the gene
expression omnibus (GEO) database (Accession ID: GSE86072).
Identiﬁcation of differentially expressed genes
Before identifying the differentially expressed genes (DEGs), we ﬁrst
deﬁned the expressed genes across SSCs, iSSCs and mSSCs using a
Gaussian mixture modeling method as previously described.15 Among
the expressed genes, we identiﬁed the DEGs from the following three
comparisons: (1) SSCs versus iSSCs, (2) iSSCs versus mSSCs and
(3) SSCs versus mSSCs, using the previously reported integrative
statistical hypothesis testing method16 that computes adjusted P-values
(P) by combining a two-sample t-test and the median ratio test. For
each comparison, the DEGs were selected from the expressed genes as
the ones with Po0.05 and log2 fold changes 40.58. A total of 6627
DEGs were identiﬁed from the three comparisons.
Categorization of DEGs by temporal expression patterns
We categorized the 6627 DEGs into 18 clusters based on their
differential expression patterns in the three comparisons (SSCs versus
iSSCs, iSSCs versus mSSCs and SSCs versus mSSCs) (Supplementary
Figure S4a). The statistical testing method employs the discrete
decision of whether a gene shows a statistically signiﬁcant change
between two conditions, and this discrete decision cannot detect
marginal expression changes of the gene. To incorporate the marginal
changes into the clustering of DEGs, we further performed a second
clustering that clusters the mean proﬁles of the 18 clusters
(Supplementary Figure S4b) using a hierarchical clustering method
(Euclidean distance and average linkage). From the hierarchical
clustering result, we ﬁnally identiﬁed twelve groups of DEGs (groups
1–12) such that the DEGs in each group showed the same differential
expression pattern (Supplementary Figure S4c).
Identiﬁcation of the cellular processes enriched by the genes
in groups 1–12
To identify the cellular processes associated with the DEGs in groups
1–12, we performed an enrichment analysis of GOBPs for the DEGs in
each group using DAVID Bioinformatics Resources V6.7.17 The
GOBPs with a P-value o0.1 (the default cut off in DAVID) and a
count ⩾ 3 were selected as cellular processes enriched by the genes in
each group.
Identiﬁcation of major TFs
To identify major TFs for a set of DEGs, we performed a TF target
enrichment analysis for the DEGs in each of groups 1–12 using
MetaCore,18 which calculated the signiﬁcance (P-value) of the number
of targets of each TF from a hypergeometric distribution. For the
multiple hypothesis testing correction, MetaCore computed a false
discovery rate (FDR) from the P-value for each TF. The TFs with an
FDRo0.05 and a target gene count ⩾ 5 were deﬁned as major TFs in
each group. Some TFs, including Creb1, Sp1 and Sp2, were excluded
from the major TFs because they had signiﬁcant numbers of
non-speciﬁc targets in almost all of the groups.
Identiﬁcation of pluripotency-related groups of DEGs
To examine which groups of DEGs showed signiﬁcant overlaps
with pluripotency-related genes in mESCs, we used the previously
reported19 gene expression proﬁles (GSE2972, GSE3749 and
GSE3231) generated from three mESC lines with different genetic
backgrounds, R1, V6.5 and J1, and EBs after differentiation (6, 12, 18,
24 and 36 h, and 2, 4, 7, 9 and 14 days). The log2 intensities were
normalized using the GC-RMA package in Bioconductor.20 In each
time-course dataset, log2 fold changes for each probe set were then
calculated by subtracting the log2 intensity of the mESCs from those at
all time points, resulting in a k×10 log2 fold-change matrix, where k is
the number of probe sets. In total, three fold-change matrices were
generated. After transforming each of these three matrices into a single
vector, the three vectors were normalized using the quantile normal-
ization method to avoid bias toward datasets with large fold-changes
and then were transformed back into three matrices. Finally, the three
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matrices with normalized log2 fold changes were combined by
matching the probe set IDs, resulting in a combined log2 fold-
change matrix. Non-negative matrix factorization (NMF) was then
applied to the combined matrix as previously described.21 The number
of clusters was set to be 40. The genes belonging to each cluster were
selected as the ones with a P-value o0.05. From the 40 clusters, the
clusters showing an overall up- and down-regulation during differ-
entiation across all three mESC lines were selected as differentiation-
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and pluripotency-related genes (with a fold change ⩾ 1.5 for at least
one time point during differentiation), respectively. The P-value for
the overlap of the differentiation- or pluripotency-related genes with
each group of DEGs was computed based on the null hypothesis
distribution of the number of overlapped genes using random
sampling experiments for the DEG group being analyzed.
Reconstruction of the TRNs delineating cell proliferation,
glycolysis and epigenetic regulation
To reconstruct TRNs for each of three pluripotency-related processes
(stem cell maintenance, cell proliferation-related processes and
epigenetic regulation), we ﬁrst selected the DE-mTFs that strongly
regulate the genes involved in the process (Figure 4d; see ‘Results’
section) and then targeted the genes in group 1 or 3 with the GOBPs
for the process based on the protein–DNA interactions from
MetaCore.18 Using the sets of TFs and target genes and the relation-
ships between the TFs and target genes, the TRN for each of the three
processes was then reconstructed and displayed using Cystoscope
software.22 Protein–protein interactions among the nodes (TFs and
target genes) were obtained from the following interactome databases
and then added to the TRN: BioGRID,23 IntAct,24 MINT,25 DIP26 and
I2D.27 The nodes in the TRN were arranged based on the KEGG
pathway associated with each of the three pluripotency-related
processes.
Reverse transcription-polymerase chain reaction
For the reverse transcription-polymerase chain reaction (RT-PCR)
analysis, 1 μg of DNase I-treated total RNA was reverse-transcribed
using Superscript II reverse transcriptase with random hexamers
(Invitrogen, Carlsbad, CA, USA) according to the manufacturer’s
instructions. The standard PCR conditions were as follows: 4 min at
94 °C, followed by 25–35 cycles of 30 s at 94 °C, 30 s at 55 °C and 30 s
at 72 °C. The primer sequences used in this study are given in
Supplementary Table S6.
RESULTS
Gene expression signatures related to the reprogramming of
SSCs to mSSCs
To understand the reprogramming of SSCs to mSSCs, we ﬁrst
developed mSSCs derived from SSCs as previously described.28
During the SSC-to-mSSC reprogramming, colonies of iSSCs
appeared after two to three passages, and we then isolated
and grew these iSSCs in the ESC culture medium for nine
additional passages, leading to mSSCs. To identify the
gene expression signatures related to the SSC-to-mSSC
reprogramming, we ﬁrst performed gene expression proﬁling
of SSCs, iSSCs and mSSCs using an Illumina MouseRef-8 v2.0
BeadChip containing probes for 17 860 annotated genes. Using
the resulting gene expression proﬁles, we then performed the
following comparisons: (1) iSSCs versus SSCs, (2) mSSCs
versus SSCs and (3) mSSCs versus iSSCs. From these three
comparisons, we identiﬁed 1521, 5715 and 5226 DEGs,
respectively (Figure 1a). To understand the temporal transition
of gene expression during the SSC-to-mSSC reprogramming,
we next categorized the DEGs into 12 groups (Figure 1b)
based on their differential expression patterns in the three
comparisons as described in ‘Materials and Methods’ section
(Supplementary Table S1). Of these groups, groups 1 and 7
(560 and 734 DEGs, respectively) showed a gradual increase
and decrease in expression, respectively, during reprogram-
ming. Groups 2 and 8 (150 and 310 DEGs, respectively)
showed an increase and decrease, respectively, during the early
transition from SSCs to iSSCs and then maintained these
changes during the late transition from iSSCs to mSSCs,
whereas groups 3 and 9 (2083 and 1648 DEGs, respectively)
showed expression changes speciﬁcally during the late
transition. Finally, groups 4–6 and 10–12 showed expression
changes during the early transition, but restored the changes
partially (groups 4 and 10), completely (groups 5 and 11) or
excessively (groups 6 and 12) during the late transition. These
data indicate that the SSC-to-mSSC reprogramming involves
various modes of temporal gene expression changes.
Cellular processes associated with the reprogramming of
SSCs to mSSCs
To examine the cellular processes associated with the
SSC-to-mSSC reprogramming, we then identiﬁed the Gene
Ontology Biological Processes (GOBPs) represented by the
twelve groups of DEGs using the DAVID software17 (Figure 1c;
Supplementary Table S2). Of the twelve groups, group 3,
showing late changes during the reprogramming, was
associated with cellular processes related to pluripotency and
self-renewal, including (1) stem cell maintenance, (2) cell
proliferation-related processes (cell cycle, DNA replication,
M phase of mitotic cell cycle, DNA repair, cell cycle checkpoint
and cell division) and (3) epigenetic regulation-related pro-
cesses (histone acetylation and methylation). Of these pro-
cesses, several of the cell proliferation-related processes (cell
cycle, DNA replication, M phase of mitotic cell cycle and DNA
repair) were commonly associated with group 1, which showed
early changes during the reprogramming. These data suggest
that cell proliferation began to be activated in the early
Figure 1 DEGs during the reprogramming of SSCs to mSSCs. (a) DEGs identiﬁed from the three comparisons (mSSCs versus SSCs, mSSCs
versus iSSCs and iSSCs versus SSCs). The Venn diagram shows the relationships among the DEGs in individual comparisons. The numbers
in parentheses denote the numbers of DEGs identiﬁed in the individual comparisons. (b) Different expression patterns of DEGs in groups
1–12 during the reprogramming of SSCs to mSSCs. To clearly show the temporal differential expression patterns, the gene expression data
in individual groups of DEGs were normalized to have zero mean values and unit standard deviations. Thick lines represent the median
proﬁles of gene expression in groups 1–12. X-axis, replicates in SSCs, iSSCs and mSSCs; Y-axis, auto-scaled expression levels. (c) GOBPs
associated with the genes in groups 1–12. The color in the heat maps represents − log10(P), in which P is the enrichment P-value obtained
from the DAVID software for the corresponding GOBP. Different colors were used for four different groups of DEGs. In addition, the colored
GOBP labels indicate the three pluripotency-related processes (stem cell maintenance (red), cell proliferation-related processes (blue), and
epigenetic regulation (green)) and differentiation-related pathways and processes (orange).
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transition from SSCs to iSSCs (group 1), whereas the other
pluripotency-related processes were activated primarily during
the late transition from iSSCs to mSSCs (group 3). Moreover,
interestingly, groups 7–9, showing early or late decreases
in expression, were associated with cellular processes
(morphogenesis for differentiation and sex differentiation)
and signaling pathways (TGFβ, Wnt and VEGF signaling
pathways)29 related to the differentiation of SSCs, suggesting
that these differentiation-related processes are inactivated
during the reprogramming. Thus, these data collectively
indicate that the SSC-to-mSSC reprogramming involves
a transcriptional program that involves the temporally
coordinated activation and inactivation of pluripotency- and
differentiation-related processes during the course of the
reprogramming.
Identiﬁcation of the major TFs associated with the SSC
reprogramming
Transcriptional regulation is a primary mechanism necessary to
acquire pluripotency, as demonstrated in the reprogramming
of human and mouse ﬁbroblasts to iPSCs. Pluripotency-
inducing TFs, such as Oct4/Pou5f1, Sox2, Myc and Klf4, have
been used to reprogram ﬁbroblasts into iPSCs.11,12 Thus,
decoding the TRNs underlying the gene expression changes
in groups 1–12 (Figure 1b) is essential to understanding the
SSC-to-mSSC reprogramming. To decode the core transcrip-
tional regulations, we ﬁrst identiﬁed 93 major TFs that had
signiﬁcant (FDRo0.05 and number of target genes ⩾ 5)
numbers of target genes in groups 1–12 based on the
TF-target gene information obtained from MetaCore.18
Moreover, the differentially expressed TFs (DETFs) during
the course of the reprogramming could signiﬁcantly contribute
to transcriptional regulation of their target genes in groups
1–12. Thus, we further identiﬁed 241 DETFs among the
genes in groups 1–12. These two sets of major TFs and DETFs
can be categorized into three groups (Figure 2a): (1) 41
non-differentially expressed major TFs (non-DE-mTFs),
(2) 52 differentially expressed major TFs (DE-mTFs) and
(3) 188 differentially expressed, but non-major TFs (DE-TFs).
We then examined the relative proportions of the DEGs that
can be regulated by the three TF groups. Of the three groups,
the 52 DE-mTFs had the largest numbers of target genes in
groups 1–12 and links to the target genes (Figure 2b, left and
right, respectively; Supplementary Table S3). Moreover, the 52
DE-mTFs had signiﬁcant numbers of target genes across all the
groups, except for group 10, which was the smallest among
groups 1–12 (Figure 2c). These data indicate that of the three
groups of TFs, the 52 DE-mTFs contribute most signiﬁcantly
to the transcriptional regulation of the DEGs in groups 1–12.
Thus, we focused on these 52 DE-mTFs for the analysis of the
TRNs underlying the SSC-to-mSSC reprogramming.
Transcriptional regulatory relationships between major TFs
and pluripotency-related genes
Our aim was to understand the TRN that describes the
regulation of pluripotency-related genes by the 52 DE-mTFs
during the SSC-to-mSSC reprogramming. The GOBP
enrichment analysis of groups 1–12 above showed that groups
1 and 3 included the DEGs closely associated with pluripotency
(Figure 1c), suggesting that some groups of DEGs are more
relevant to pluripotency. To identify the groups of DEGs that
are more relevant to pluripotency, we ﬁrst selected 844
pluripotency-related and 1,178 differentiation-related genes
whose expression decreased and increased, respectively,
commonly during the differentiation of three different mouse
ESC lines (R1, V6.5 and J1) to embryoid bodies (EBs)
(Supplementary Figure S1a; Supplementary Table S4) by
analyzing the previously reported gene expression proﬁles
(GSE2972, GSE3749 and GSE3231)19 (‘Materials and Methods’
section). We then compared these genes with groups 1–12 and
found that groups 1 and 3 showed the most signiﬁcant
(Po10− 5) overlaps with the 844 pluripotency-related genes,
whereas groups 7 and 9 showed the most signiﬁcant overlaps
with the 1178 differentiation-related genes (Figure 3a). This
analysis suggests that groups 1 and 3 should be the most
relevant to the pluripotency acquired in mSSCs during the
SSC-to-mSSC reprogramming, which was consistent with the
ﬁnding from the GOBP enrichment analysis of groups 1–12
(Figure 1c). Thus, to decode the TRN underlying the
pluripotency acquired in mSSCs, we focused on groups 1
and 3, which showed early and late changes during the course
of the SSC-to-mSSC reprogramming.
To understand the transcriptional regulatory relationships
between the DE-mTFs and their target genes in groups 1 and 3,
we then examined how many genes in groups 1 and 3 are
regulated by the DE-mTFs. Interestingly, of the 52 DE-mTFs,
5 and 14 (a total of 15 DE-mTFs) signiﬁcantly (FDRo0.05)
regulated the genes in group 1 (158 of 560 genes) and group 3
(780 of 2083 genes), respectively (Figure 3b). Moreover, the
target genes of these DE-mTFs in groups 1 and 3 could
signiﬁcantly represent the pluripotency-related cellular pro-
cesses (Figure 1b) represented by all the genes in groups 1 and
3 (Figure 3c). The 158 target genes in group 1 were associated
with cell proliferation-related processes (cell cycle, DNA
replication, M phase of mitotic cell cycle, DNA repair)
(Figure 3c, left). In addition, the 780 target genes in group 3
were associated with stem cell maintenance, cell proliferation-
related processes (cell cycle, DNA replication, M phase of
mitotic cell cycle, DNA repair, cell cycle checkpoint and cell
division), and epigenetic regulation-related processes (histone
acetylation and methylation) (Figure 3c, right).
More speciﬁcally, four of the 5 DE-mTFs for group 1
(Oct4/Pou5f1, Cux1, Zfp143 and E2f4) strongly regulated the
target genes in group 1 associated with cell proliferation-related
processes (cell cycle, DNA replication, M phase of mitotic cell
cycle and DNA repair) (Figure 3d, left). In addition, seven of
the 14 DE-mTFs for group 3 (Oct4/Pou5f1, Nanog, Foxm1,
Cux1, Zfp143, Trp53 and E2f4) strongly regulated the genes
in group 3 associated with cell proliferation-related processes
(cell cycle, DNA replication, M phase of mitotic cell cycle,
DNA repair, cell cycle checkpoint and cell division) (Figure 3d,
right). Moreover, another seven (Oct4/Pou5f1, Nanog, Sox2,
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Klf4, Esrrb, Nfyb and Foxm1) strongly regulated the genes in
group 3 associated with stem cell maintenance, whereas
eight (Oct4/Pou5f1, Nanog, Sox2, Esrrb, Cux1, Zfp143, Trp53
and E2f4) regulated the genes in group 3 associated with
epigenetic regulation-related processes (histone acetylation and
methylation) (Figure 3d, right). These data indicate that the
regulation of the target genes in groups 1 and 3 by the 15
DE-mTFs represent the transcriptional regulatory relationships
required for the pluripotency acquired in mSSCs during the
SSC-to-mSSC reprogramming. A PCR analysis conﬁrmed
the differential expression of four representative DE-mTFs
(Oct4/Pou5f1, Sox2, Esrrb and Nanog) and their representative
target genes involved in stem cell maintenance (Esrrb, Fgf4,
Lin28a, Mtf2, Nanog, Nodal, Oct4/Pou5f1, Sox2 and Tfap2c)
and epigenetic regulation (Actl6a, Eed, Kat6b, Kat7, Phf17,
Prmt8 and Suz12), as well as three representative DE-mTFs
(Zfp143, Trp53 and E2f4) and their representative target genes
involved in cell proliferation-related processes (Aspm, Ccnb1,
Cdk1, Cdk2, Dlgap5, Kif11, Kntc1, Mad2l1, Pttg1, Plk1 and
Rad51) (Figure 3e).
Hypothetical TRNs delineating the pluripotency-related
processes during the reprogramming of SSCs to mSSCs
We next reconstructed hypothetical TRNs that describe the
regulation of the pluripotency-related processes (stem cell
maintenance, cell proliferation and epigenetic regulation) by
the 15 DE-mTFs, based on the transcriptional regulatory
relationships mentioned above between the 15 DE-mTFs and
the genes in groups 1 and 3 associated with the pluripotency-
related processes. It has been shown that pluripotency-inducing
TFs, such as Oct4/Pou5f1, Sox2, Myc and Klf4, act as the most
essential factors for stem cell maintenance.11,12 In addition to
these TFs, recently, a number of regulatory factors, including
Nanog, Lin28 and Glis1, have also been reported to be essential
for stem cell maintenance.30,31 The TRN for stem cell main-
tenance showed dense transcriptional regulatory relationships
Figure 2 Major TFs predominantly regulating the DEGs during the reprogramming of SSCs to mSSCs. (a) Venn diagram showing the
relationships among 93 major TFs and 241 DETFs. These TFs were categorized into three groups (I: 41 non-DE-mTFs; II: 52 DE-mTFs;
and III: 188 DE-TFs). The overlap between the two sets of TFs was found to be signiﬁcant (Po1×10−4 from hypergeometric test).
(b) Relative proportions of DEGs regulated by the three groups of TFs (target genes, left) and the numbers of links between DEGs and the
three groups of TFs (Protein–DNA interactions, right). (c) Heat maps showing the signiﬁcance of the target genes in groups 1–12 that are
regulated by the 52 DE-mTFs. The FDR was computed as the signiﬁcance measure (‘Materials and Methods’ section). The color represents
–log10(FDR). Different colors were used for four different groups of DEGs.
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among a set of regulatory factors (Figure 4a), including seven
TFs (Oct4/Pou5f1, Sox2, Nanog, Klf4, Esrrb, Foxm1 and Nfyb),
two signaling molecules (Nodal and Fgf4), and a DNA
replication factor (Rif1). Nfyb in group 1 was up-regulated to
positively regulate Oct4/Pou5f1, Sox2 and Fgf4 in group 3 in the
early phase of the SSC-to-mSSC reprogramming, and the
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regulatory factors in group 3 showed tight regulatory relation-
ships among themselves. Interestingly, the expression of Klf4
decreased during the early phase of the reprogramming and
then was restored to positively regulate the regulatory factors in
group 3 (Oct4/Pou5f1, Sox2, Nodal, Nanog and Esrrb) during
the late phase of the reprogramming. Altogether, these data
suggest the temporal coordination of transcriptional regulation
among the regulators associated with stem cell maintenance
during the SSC-to-mSSC reprogramming.
Pluripotent stem cells have increased cell cycle activity,
reﬂecting their rapid cell division, which is indicated by a
short G1 phase for fast cell cycle progression and enhanced
genomic integrity due to fewer accumulated genetic lesions.32
The TRN for the cell proliferation (Figure 4b) showed that the
genes involved in the following processes associated with fast
cell cycle progression were up-regulated during the early phase
of the reprogramming (group 1): G1–S transition (Tfdp1),
DNA replication at S phase (Mcm2/5, Polk/e, Prim2, Dbf4 and
Cdc6) and M phase (Bub3, Espl1, Ccnf and Cdc5I). Moreover,
the genes involved in DNA repair (Rad54, Fancd2, Msh6,
Eef1e1, Chaf1a, Mgm, Gtf2h1, Sod2 and Apex1) that are
associated with enhanced genomic integrity were also up-
regulated during the early phase (group 1) (Supplementary
Figure S2). These early up-regulated genes are regulated mainly
by four DE-mTFs (E2f4, Zfp143, Oct4/Pou5f1 and Cux1), as
shown in Figure 3d. The TRN also showed that a majority of
the genes involved in cell cycle progression and genomic
integrity were up-regulated during the late phase of the
reprogramming (group 3; red nodes in Figure 4b) and were
regulated predominantly by seven DE-mTFs (E2f4, Zfp143,
Oct4/Pou5f1, Nanog, Trp53, Cux1 and Foxm1), as shown in
Figure 3d. These data demonstrate the temporal coordination
of the transcriptional regulation of cell proliferation-related
processes by these seven DE-mTFs during the early and late
phases of the SSC-to-mSSC reprogramming.
It has been shown that the reprogramming of epigenetic
regulation is also important for acquiring pluripotency.33 The
TRN for epigenetic regulation showed the factors up-regulated
during the late phase of the SSC-to-mSSC reprogramming
(Figure 4c). These factors included mostly histone
acetyltransferases and methyltransferases, to open chromatin
states and repress the expression of development-related genes,
respectively. Of the histone acetyltransferases, in particular,
Tip60–p400 complex genes (Brd8, Ing3 and Actl6a) and GCN5
(Kat2a/b) and Myst (Myst2/4) family genes, as well as Hat1 and
Phf17, were up-regulated during the late phase. Of the histone
methyltransferases, PRC2 complex genes (Eed, Suz12 and Ezh2)
and PRMT family genes (Prmt1/8), as well as Suv420h2, were
up-regulated. The TRN showed that these genes were regulated
predominantly by eight DE-mTFs (Cux1, Oct4/Pou5f1, Sox2,
Zfp143, Trp53, Esrrb, Nanog and E2f4), as shown in Figure 3d.
Interestingly, of them, Cux1 was down-regulated during the
early phase of the reprogramming, whereas the other seven TFs
were up-regulated during the late phase. This indicates that the
regulation of epigenetic factors by Cux1 was suppressed,
followed by positive regulation of these factors by the
other seven TFs, suggesting temporal coordination in the
transcriptional regulation of the epigenetic regulation by
the eight DE-mTFs during the SSC-to-mSSC reprogramming.
DISCUSSION
In this study, we attempted to decode the TRN underlying the
reprogramming of SSCs to mSSCs through a comparative
analysis of gene expression proﬁles obtained from SSCs, iSSCs
and mSSCs and an integrative analysis of (1) DEGs during the
SSC reprogramming and (2) TF-target information. These
analyses revealed that three key cellular processes (stem cell
maintenance, cell proliferation-related processes and epigenetic
regulation) were closely associated with the pluripotency
acquired during the SSC-to-mSSC reprogramming. These
TRNs suggested important features of temporal coordination
in the transcriptional regulation of the genes involved in these
pluripotency-related processes during the reprogramming.
First, four DE-TFs (E2f4, Zfp143, Oct4/Pou5f1 and Cux1)
strongly regulated the genes involved in cell proliferation-
related processes during the early transition from SSCs
to iSSCs (Figure 4b). Second, seven DE-mTFs (E2f4, Zfp143,
Oct4/Pou5f1, Nanog, Trp53, Cux1 and Foxm1) strongly
regulated the genes involved in cell proliferation-related
processes, stem cell maintenance and epigenetic regulation
(Figures 4a and c).
Figure 3 Transcriptional regulatory relationships between DE-mTFs and their target genes. (a) Overlaps of groups 1–12 with pluripotency-
related genes in mESCs. Groups 1 and 3 signiﬁcantly (Po0.01) overlapped with 844 pluripotency-related genes, whereas groups 7 and 9
signiﬁcantly (Po0.01) overlapped with 1178 differentiation-related genes. The red line denotes the cutoff P-value. (b) DE-mTFs that
signiﬁcantly (FDRo0.05) regulate the genes in groups 1 and 3. The pie chart shows which groups of DEGs included the ﬁve and 14
DE-mTFs for groups 1 and 3, respectively. (c) The signiﬁcance of the GOBPs that are regulated by the 52 DE-mTFs in groups 1–12. The
signiﬁcance for each pair of DE-mTF and GOBP was estimated as the enrichment P-value (x-axis) obtained from the DAVID software for
158 and 780 target genes in groups 1 and 3, respectively. The default P-value cutoff in DAVID is denoted as red dotted lines. The red
boxes at the center indicate GOBPs signiﬁcantly enriched by all the genes in groups 1 (BP-G1) and 3 (BP-G3). (d) The signiﬁcance of the
GOBPs that are regulated by the ﬁve and 14 DE-mTFs for groups 1 (left) and 3 (right), respectively. The signiﬁcance for each pair of
DE-mTF and GOBP was computed as the fraction of the genes regulated by the DE-mTF among all the genes DEGs involved in the GOBP.
The color gradient shows the relative proportions of such genes. The red boxes at the center indicate representative GOBPs in groups 1
(BP-G1) and 3 (BP-G3). The tables show the association of the DE-mTFs with cell proliferation-related processes (red for group 1 and
orange for group 3), stem cell maintenance (blue) and epigenetic regulation (green). (e) PCR analysis of the differential expression of four
representative DE-mTFs and their representative target genes involved in stem cell maintenance and epigenetic regulation as well as three
representative DE-mTFs (Zfp143, Trp53 and E2f4) and their representative target genes involved in cell proliferation-related processes
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Our study revealed novel molecular signatures that might be
related to pluripotency. For example, the TRN for epigenetic
regulation showed that PRMT1 and PRMT8, involved in
arginine methylation, are regulated by ZFP143 and NANOG,
which regulate the expression of many pluripotency-related
genes. This suggested the potential role of arginine methylation
in the acquired pluripotency in mSSCs. In addition, the DEGs
included several aminoacyl-tRNA synthetases (ARSs). Although
ARSs have classically been thought of as housekeeping genes,
recent studies have shown that they can have pathophysiolo-
gical roles in tumorigenesis21 and other diseases.34 Among the
23 ARSs genes, 19 were up-regulated during the SSC-to-mSSC
Figure 4 TRNs delineating the pluripotency-related processes during the reprogramming of SSCs to mSSCs. (a–c) TRNs underlying the
regulation of the genes involved in pluripotency-related processes— stem cell maintenance (a), cell proliferation-related processes (b) and
epigenetic regulation (c). The node shapes represent DE-mTFs (diamond) and target genes (circles) and the node colors represent the
groups that include the nodes (see node legend box at the bottom). The arrows represent TF-target gene relationships, and the dotted lines
represent Protein–protein interactions. The same colors were used for the TFs and the arrow edges. The nodes in the three TRNs were
arranged according to the KEGG pathways associated with the three pluripotency-related processes. On the basis of the KEGG pathways,
+p and −p represent phosphorylation and dephosphorylation reactions, respectively, and the suppression symbols denote the repression
reactions. The background represents a network module that includes the nodes involved in the corresponding cellular process.
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reprogramming (Supplementary Table S5). Considering that
these ARS genes are implicated in cancer cells, which share the
ability of rapid cell proliferation with self-renewing stem
cells,35–38 the changes in expression of the ARS genes during
the SSC-to-mSSC reprogramming may indicate their potential
roles in the acquired pluripotency in mSSCs.
Rapidly dividing pluripotent stem cells have different cellular
metabolic regulation processes compared with their differen-
tiated cells. In particular, pluripotent stem cells show increased
levels of glycolysis under aerobic conditions, leading to high
glycolytic ﬂuxes to (1) generate ATP and intermediate meta-
bolites through the pentose phosphate pathway for lipid and
nucleotide biosynthesis and (2) reduce the levels of reactive
oxygen species (ROS) that can cause stem cell differentiation.39
To examine this, we also reconstructed a hypothetical TRN that
delineated the regulation of the genes involved in aerobic
glycolysis (Supplementary Figure S3). The TRN contained
seven genes (Lin28a, Pfkp, Aldoa, Pgam1, Eno1, Pdhb and
Pdk1) involved in glycolysis, which were up-regulated during
the late phase of the SSC-to-mSSC reprogramming. The
expression changes of these genes are collectively regulated by
Oct4/Pou5f1 and Nanog during the late phase. In addition, two
genes (Sod2 and Gpx1) involved in the reduction of ROS levels
are mainly regulated by Nanog and Trp53. These TFs (Pou5f1,
Nanog and Trp53) also regulate the cell cycle-related genes that
are up-regulated during the early and late reprogramming
stages (Figure 4a). These data indicate temporal coordination
in the transcriptional regulation of the cell cycle and aerobic
glycolysis by these TFs.
Owing to the incompleteness of the TF-target interactome,
our TRNs provide only a partial view of the transcriptional
regulation activated during the SSC-to-mSSC reprogramming.
Accordingly, the 15 DE-mTFs on which we focused for
understanding the transcriptional regulation during the repro-
gramming could be incomplete. In our study, we identiﬁed the
52 DE-mTFs that can contribute to the reprogramming.
ChIP-chip or ChIP-seq analysis of these DE-mTFs could
provide more complete views of the transcriptional regulation
underlying the temporal expression changes of the genes
associated with the SSC-to-mSSC reprogramming. Despite
the limitations of the TF-target interactome, however, the 15
DE-mTFs and the TRNs still provide meaningful insights into
the transcriptional regulatory mechanisms for the early and late
activation of cellular processes during reprogramming, as well
as the temporal coordination of the transcriptional regulatory
mechanisms as demonstrated in Figures 4a–c.
Our analysis revealed that ﬁve DE-mTFs (E2f4, Zfp143,
Oct4/Pou5f1, Irf8 and Cux1) strongly regulated the genes in
group 1, which were up-regulated during the early phase of the
SSC-to-mSSC reprogramming. Of the ﬁve DE-mTFs, Cux1 was
down-regulated during the early phase of the reprogramming,
but the other four were up-regulated (E2F4, Zfp143 and
Oct4/Pou5f1) or down-regulated (Irf8) during the late phase.
However, it is not clear how the three late up-regulated TFs
(E2F4, Zfp143 and Oct4/Pou5f1) can regulate the early
up-regulated genes in group 1. The DEGs were identiﬁed
based on the discrete decision of whether a gene showed a
statistically signiﬁcant change in the three comparisons (iSSCs
versus SSCs, mSSCs versus SSCs and mSSCs versus iSSCs).
This discrete decision may not be able to detect meaningful
marginal expression changes of the DE-mTFs that can
contribute to induction of the genes up-regulated during the
early phase of the SSC-to-mSSC program. However, the late
up-regulated DE-mTFs can also modulate the expression of
the early up-regulated genes during the late phase of the
reprogramming. This modulation can signiﬁcantly contribute
to the stabilization of the up-regulation of the early responsive
genes during the late phase of the reprogramming.
Our network model (Figure 4c) for epigenetic regulation
suggests that eight DE-mTFs (Cux1, Oct4/Pou5f1, Sox2, Zfp143,
Trp53, Esrrb, Nanog and E2f4) can regulate the induction of
histone methyltransferases (Eed, Suz12 and Ezh2 in the
PRC2 complex and Prmt1, Prmt8 and Suv420h2) during the
SSC-to-mSSC reprogramming. This is consistent with a pre-
vious ﬁnding that the reprogramming of epigenetic regulation
is also important for acquiring pluripotency.33 Interestingly, of
these methyltransferases, Prmt1 and Prmt8 are arginine methyl-
transferases, and their induction during the SSC-to-mSSC
reprogramming thus further suggests the potential association
of histone arginine methylation with the pluripotency
acquired by mSSCs. Consistent with this observation,
Torres-Padilla et al.40 showed that four-cell blastomeres with
reduced developmental potential had lower levels of histone
H3 arginine 17 and 26 methylation, whereas cells with higher
levels of such methylation were predisposed to contribute to
the pluripotent inner cell mass (ICM). They further showed
that the increased expression of coactivator-associated-protein-
arginine-methyltransferase 1 (Carm1) in individual blastomeres
led to increased histone methylation, resulting in a higher
expression of pluripotency TFs, such as Nanog and Sox2, and
the direction of progeny to the ICM. Altogether with these
data, our network model suggests that histone arginine
methylation by PRMT1 and PRMT8 may have an important
role in acquiring pluripotency during the SSC-to-mSSC
reprogramming, as the Carm1-dependent arginine methylation
was found to be essential in the regulation of pluripotency in
the early mouse embryo.
The temporal coordination of the transcriptional regulation
suggested by our TRNs can extend the current knowledge of
the regulation underlying the SSC-to-mSSC reprogramming.
The current understanding of the reprogramming-related
regulation mainly focuses on the roles of individual TFs that
contribute to the reprogramming. Our study extends this view
into the collective transcriptional regulation involving multiple
TFs and the dynamic coordination of their transcriptional
regulation. To develop more accurate models of the temporal
coordination of the transcriptional regulation, comprehensive
time-course global assays involving more time points during
the transition of iSSCs to mSSCs should be employed and
could provide detailed differences in the DE-mTFs and their
target genes up-regulated during the late phase of the
SSC-to-mSSC reprogramming. In conclusion, our analysis
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provides key DE-mTFs and TRNs that can be used as the bases
for understanding the serial, coordinated activation of cellular
processes during the SSC-to-mSSC reprogramming.
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